Mangalore Refinery & Petrochemicals Adjusts Valuation Amidst Industry Challenges and Performance Metrics
Mangalore Refinery & Petrochemicals (MRPL) has adjusted its valuation, revealing a PE ratio of -77.46 and a price-to-book value of 1.72. The company shows a ROCE of 3.63% and ROE of 0.43%. Despite a recent stock decline, MRPL has demonstrated substantial growth over the past five years.
Mangalore Refinery & Petrochemicals (MRPL) has recently undergone a valuation adjustment, reflecting its current financial standing within the oil industry. The company, categorized as a small-cap entity, has reported a PE ratio of -77.46, indicating challenges in profitability. Its price-to-book value stands at 1.72, while the EV to EBITDA ratio is noted at 18.96, suggesting a moderate valuation relative to earnings before interest, taxes, depreciation, and amortization.In terms of performance metrics, MRPL's return on capital employed (ROCE) is recorded at 3.63%, and return on equity (ROE) is at 0.43%, both of which highlight the company's operational efficiency. Comparatively, MRPL's peers exhibit a range of valuation metrics, with some companies in the sector classified as very expensive, while others are deemed risky due to loss-making positions.
Over the past year, MRPL has experienced a stock return of -34.83%, contrasting with a slight decline in the Sensex, which reflects broader market trends. The company's performance over longer periods, such as a 5-year return of 322.46%, indicates significant historical growth compared to the Sensex's 109.64%. This context underscores the competitive landscape MRPL navigates within the oil sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
